Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5,263.77%-460.75K | -236.11%-718.92K | 2,749.32%1.5M | -137.71%-559.74K | -268.12%-1.02M | -101.77%-8.59K | 360.75%528.19K | -120.45%-56.71K | 131.88%1.48M | 1,169.47%608.29K |
| Net income from continuing operations | 41.50%455K | -5.75%391.6K | -70.24%95.89K | 46.78%814.05K | -379.61%-245.16K | 13.79%321.55K | 412.31%415.5K | 211.97%322.16K | -73.40%554.63K | -94.84%87.68K |
| Depreciation and amortization | -29.54%63.79K | -1.06%87.7K | -61.37%35.55K | -18.85%306.11K | -62.98%34.91K | -4.01%90.53K | -6.01%88.63K | -2.41%92.04K | -7.66%377.22K | -2.27%94.3K |
| Asset impairment expenditure | --0 | 433.33%20K | 420.00%52K | 116.02%5.95K | 112.10%1.95K | --0 | 89.48%-6K | -44.44%10K | -389.02%-37.13K | ---16.1K |
| Remuneration paid in stock | 190.32%85.89K | 578.26%51.96K | 403.83%20.53K | 30.25%71.47K | 256.89%30.15K | -24.13%29.59K | 162.78%7.66K | -9.77%4.08K | 47.08%54.87K | 21.80%8.45K |
| Deferred tax | 3,568.54%204.41K | -76.86%33.18K | 38.46%109.53K | 30.28%357.33K | 35.50%129.26K | -95.74%5.57K | 1,263.05%143.39K | 109.93%79.11K | 117.59%274.28K | 106.12%95.39K |
| Other non cashItems | 1,489.11%66.68K | 291.75%66.14K | 328.73%73.74K | 1,925.62%55.52K | -1.43%17.24K | 163.80%4.2K | 330.00%16.88K | 360.16%17.2K | 76.58%-3.04K | 270.00%17.49K |
| Change In working capital | -190.53%-1.34M | -893.29%-1.37M | 291.84%1.12M | -923.32%-2.17M | -408.64%-990.99K | -523.64%-460.03K | -1,302.44%-137.87K | -2,327.08%-581.29K | 179.48%263.59K | 211.22%321.08K |
| -Change in receivables | 28.74%-1.4M | -295.86%-2.23M | 352.40%1.55M | -3,695.37%-3.27M | -137.29%-120.81K | -1,198.19%-1.97M | -436.61%-562.24K | -99.00%-612.51K | 111.31%90.84K | 639.33%323.98K |
| -Change in inventory | 127.90%126.29K | 138.93%45.06K | -234.01%-40.12K | -8,085.47%-381.47K | 168.16%157.07K | -3,462.28%-452.73K | -243.73%-115.74K | -82.12%29.93K | 2.36%4.78K | -505.39%-230.46K |
| -Change in prepaid assets | -85.53%44.65K | -95.24%4.74K | 88.51%-12.42K | 191.15%279.45K | 75.54%-20.66K | 12.79%308.57K | 120.28%99.59K | -2,187.85%-108.06K | -264.75%-306.57K | -973.66%-84.45K |
| -Change in payables and accrued expense | -108.06%-107.49K | 74.63%841.04K | -1,077.34%-280.43K | 125.07%1.07M | -339.83%-775.97K | 394.69%1.33M | -6.68%481.62K | -67.03%28.69K | 48.32%474.3K | 262.23%323.56K |
| -Change in other working capital | -98.66%4.32K | 15.79%-34.61K | -221.38%-97.9K | 54,951.48%130.47K | -1,896.57%-230.62K | 621.28%321.54K | -283.60%-41.1K | -4.20%80.65K | 100.61%237 | -1,380.90%-11.55K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5,263.77%-460.75K | -236.11%-718.92K | 2,749.32%1.5M | -137.71%-559.74K | -268.12%-1.02M | -101.77%-8.59K | 360.75%528.19K | -120.45%-56.71K | 131.88%1.48M | 1,169.47%608.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 96.95%-211 | -9.26K | -334.72K | -28.35%-13.65K | -11.18%-6.73K | -6.92K | 0 | 0 | 68.67%-10.64K | -64.11%-6.05K |
| Net PPE purchase and sale | -36.93%-9.47K | --0 | ---2.22K | -28.35%-13.65K | -11.18%-6.73K | ---6.92K | --0 | --0 | 68.67%-10.64K | -64.11%-6.05K |
| Net business purchase and sale | --9.26K | ---9.26K | ---332.5K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 96.95%-211 | ---9.26K | ---334.72K | -28.35%-13.65K | -11.18%-6.73K | ---6.92K | --0 | --0 | 68.67%-10.64K | -64.11%-6.05K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,746.79%91.6K | 4.86%-34.25K | 57.27%-60.2K | -86.72%-127.16K | 157.19%44.78K | -90.82%4.96K | 53.14%-36K | -527.40%-140.9K | -209.61%-68.1K | -266.21%-78.3K |
| Net issuance payments of debt | -546.42%-62.5K | -73.61%-62.5K | 18.00%-61.5K | -301.50%-133K | -4.35%-36K | -86.92%14K | -4.35%-36K | -368.18%-75K | -51.82%66.01K | -153.56%-34.5K |
| Net common stock issuance | --0 | --0 | 91.71%-6.2K | 55.02%-115.81K | --0 | 22.54%-41.04K | --0 | -647.72%-74.77K | -205.21%-257.49K | -779.46%-152.18K |
| Proceeds from stock option exercised by employees | 381.56%154.1K | --28.25K | -15.48%7.5K | -1.40%121.66K | -25.46%80.78K | --32K | --0 | -40.84%8.87K | 1,198.74%123.38K | --108.38K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,746.79%91.6K | 4.86%-34.25K | 57.27%-60.2K | -86.72%-127.16K | 157.19%44.78K | -90.82%4.96K | 53.14%-36K | -527.40%-140.9K | -209.61%-68.1K | -266.21%-78.3K |
| Net cash flow | ||||||||||
| Beginning cash position | -5.94%4.5M | 33.37%5.77M | -3.76%4.46M | 43.56%4.63M | 17.08%4.81M | 33.88%4.78M | 22.30%4.32M | 43.56%4.63M | 26.12%3.23M | 26.79%4.11M |
| Current changes in cash | -3,401.36%-369.36K | -254.91%-762.43K | 660.44%1.11M | -149.84%-700.55K | -287.92%-984.58K | -101.96%-10.55K | 1,286.06%492.19K | -164.17%-197.61K | 110.32%1.41M | 3,993.13%523.94K |
| Effect of exchange rate changes | -74.08%10.6K | -1,330.69%-507.61K | 279.18%200.28K | --526.17K | --632.54K | --40.89K | ---35.48K | ---111.78K | --0 | --0 |
| End cash Position | -13.99%4.14M | -5.94%4.5M | 33.37%5.77M | -3.76%4.46M | -3.76%4.46M | 17.08%4.81M | 33.88%4.78M | 22.30%4.32M | 43.56%4.63M | 43.56%4.63M |
| Free cash from | -2,931.93%-470.22K | -236.11%-718.92K | 2,745.41%1.5M | -138.91%-573.39K | -270.92%-1.03M | -103.20%-15.51K | 370.21%528.19K | -120.62%-56.71K | 143.11%1.47M | 1,094.34%602.24K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.